Tu Wangjie, Theisen Rachel Q, Jin Pengfei, Chenoweth David M, Patel Amish J, Good Matthew C
Bioengineering Graduate Group, University of Pennsylvania, PA 19104.
Department of Cell and Developmental Biology, University of Pennsylvania, PA 19104.
bioRxiv. 2024 Dec 11:2024.11.26.625566. doi: 10.1101/2024.11.26.625566.
Cells contain membrane-bound and membraneless organelles that operate as spatially distinct biochemical niches. However, these subcellular reaction centers lose fidelity with aging and as a result of disease. A grand challenge for biomedicine is restoring or augmenting cellular functionalities. Although commonly tackled by gene replacement therapy, an excited new strategy is the delivery of protein-based materials that can directly interact with and alter biological networks inside a cell. In this study we sought to develop long-lasting materials capable of cellular uptake and incorporation, akin to an artificial organelle or intracellular interaction hub. Drawing inspiration from protein-based membranelles organelles, we developed a new delivery method to transplant micron size peptide-based compartments into living cells. We determined conditions to form large stable coacervates that are efficiently taken up by a variety of useful cell types and demonstrate their intracellular stability over time. We developed tools to enhance the extent and spatial organization of cargo loading into these coacervates, including co-assembly of nanobodies that selectively bind to targets of interest. Combining them together, we demonstrate successful targeting of GFP protein inside cells. These results represent an important first step toward the development of deliverable synthetic organelles that can be fabricated in vitro and taken up by cells for applications in cell engineering and regenerative medicine.
细胞含有膜结合和无膜细胞器,它们作为空间上不同的生化微环境发挥作用。然而,这些亚细胞反应中心会随着衰老和疾病而失去保真度。生物医学面临的一个重大挑战是恢复或增强细胞功能。虽然通常通过基因替代疗法来解决,但一种令人兴奋的新策略是递送基于蛋白质的材料,这些材料可以直接与细胞内的生物网络相互作用并改变它们。在这项研究中,我们试图开发能够被细胞摄取和整合的长效材料,类似于人工细胞器或细胞内相互作用中心。从基于蛋白质的微膜细胞器中获得灵感,我们开发了一种新的递送方法,将微米级基于肽的区室移植到活细胞中。我们确定了形成大的稳定凝聚层的条件,这些凝聚层能被多种有用的细胞类型有效摄取,并证明它们在细胞内随时间的稳定性。我们开发了工具来提高货物装载到这些凝聚层中的程度和空间组织,包括共同组装选择性结合感兴趣靶标的纳米抗体。将它们结合在一起,我们展示了在细胞内成功靶向绿色荧光蛋白。这些结果代表了朝着开发可递送的合成细胞器迈出的重要第一步,这种细胞器可以在体外制造并被细胞摄取,用于细胞工程和再生医学应用。